Day One – Wednesday, 08 February 2012
8:00 – 9:00 Registration
9:00 – 9:05 Opening Ceremony & Holy Quran
9:05 – 9:10 Introductory Remarks: Executive Director of CEOR
9:10 – 9:15 Inspirational Talk: HE President of KAU
9:15 – 9:25 Awards and Recognition
9:25 – 10:00 Tour of Accompanying Exhibition
Scientific Session One
PLENARY SESSION I (10:00 – 11:05)
10:00 – 10:25 Molecular and Cellular Basis of bone Biology: The main players in bone formation and resorption and how osteoporosis develops.
Prof. Abdul Badi Abou-Samra (Detroit, MI)
10:25 – 10:50 Epidemiology of Osteoporosis: Current status in the Middle East
Prof. MSM Ardawi (KAU-Jeddah, KSA)
10:50 – 11:05 Case Studies Dr. Suzan Attar (KAU-Jeddah, KSA)
11:05 – 11:20 Coffee Break
PLENARY SESSION II (11:20 – 12:25)
11:20 – 11:45 Management of Osteoporosis in the Elderly
Prof. Rene Rizzoli (GUH-Geneva, Switzerland)
11:45 – 12:10 Bone Turnover Markers in Clinical Practice
Prof. William D. Fraser (East-Anglia, UK)
12:10 – 12:25 Case Studies
Dr. Sahar Sebaie (Saudi Aramco, Dhahran-KSA)
12:25 – 1:25 Prayers and Lunch
Scientific Session Two
PLENARY SESSION III (1:25 – 3:20)
1:25 – 1:50 Non-invasive Evaluation of Bone Strength
Prof. Ralph Muller (Zurich, Switzerland)
1:50 – 2:15 Drug-induced osteoporosis, corticoids excluded
Prof. Leith Zakraoui (Tunisia)
2:15 – 2:40 Osteoporosis: Recent trends in management, what is in the horizon?
Prof. Eugene V. McCloskey (Sheffield, UK)
ROUND TABLE DISCUSSION #1
2:40 – 3:20 RTD#1: Importance of National Guidelines for the Management of Osteoporosis
3:20 – 3:35 Prayers and Coffee Break
PLENARY SESSION IV (3:35 – 4:45)
3:35 – 4:00 Nutrition and Bone Health
Prof. Susan Lanham-New (Surrey, UK)
4:00 – 4:25 Vitamin-D status in Saudi Arabia & Middle East
Prof. MSM Ardawi (KAU-Jeddah, KSA)
4:25 – 4:45 Concluding Remarks
Day Two – Thursday, 9 February 2012
Scientific Session One
PLENARY SESSION V (8:30 – 9:45)
8:30 – 8:55 Mechanisms that Regulate Inflammation & Oral Bone Loss
Prof. Philip Stashenko (Forsyth, USA)
8:55 – 9:20 Skeletal Stem Cells: Targets for Anabolic Therapy of Osteoporosis
Prof. Moustapha Kassem (Odense, Denmark)
9:20 – 9:45 Pharmacogenomics in Osteoporosis Management
Prof. Shaker A. Mousa (NY, USA)
9:45 – 10:00 Coffee Break
PLENARY SESSION VI (10:00 – 12:00)
10:00 – 10:25 Frailty & Sarcopenia: State-of-the-art
Prof. Rene Rizzoli (Geneva, Switzerland)
10:25 – 10:50 The FRAX – Algorithm and its Clinical Implications
Prof. Eugene V. McCloskey (Sheffield, UK)
10:50 – 11:15 Why bones fail: Structure and Function
Prof. Ralph Muller (Zurich, Switzerland)
ROUND TABLE DISCUSSION #2
11:15 – 12:00 RTD#2: Management of Patients with Vitamin-D Deficiency
12:00 – 1:00 Prayers and Launch
Scientific Session Two
PLENARY SESSION VII (1:00 – 4:15)
1:00 – 1:25 Male Osteoporosis
Prof. Serge Ferrari (Geneva, Switzerland)
1:25 – 1:50 Secondary Osteoporosis
Dr. Yousef Saleh (Riyadh, KSA)
1:50 – 2:15 Bone Health and Cancer: What is New?
Prof. Mahmoud S. Al-Ahwal (KAU-Jeddah, KSA)
2:15 – 2:40 Inflammatory Diseases and Bone
Dr. Basel Masri (Amman, Jordan)
ROUND TABLE DISCUSSION #3
2:40 – 3:30 RTD#3: Fragility Fracture Prevention – local and other experiences
3:30 – 3:45 Prayers and Coffee Break
3:45 – 4:15 Concluding Remarks